MBRX (Moleculin Biotech) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MBRX Moleculin Biotech Inc MBRX
30 GF Score
Price $2.21
! 1 Warning Sign
View Full Analysis

What is Moleculin Biotech FFO per Share?

FFO per Share only applies to REITs.

MBRX
30GF Score
Moleculin Biotech Inc MBRX
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Moleculin Biotech Business Description

Other Exchanges 0K2H:UK
Address 5300 Memorial Drive, Suite 950, Houston, TX, USA, 77007
Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cancers and viruses with clinical and preclinical research funded by investigators at academic institutions. The Company operates in one reportable segment, which is the development and commercialization of drug products.
30GF Score

Get the complete analysis for MBRX

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.21
Price